Health consequences of exposure to aircraft contaminated air and fume events: a narrative review and medical protocol for the investigation of exposed aircrew and passengers.

Aerotoxic syndrome Aircrew Bleed air Cabin air Fume events Oil fumes Organophosphates

Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
16 05 2023
Historique:
received: 21 12 2022
accepted: 31 03 2023
medline: 18 5 2023
pubmed: 17 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Thermally degraded engine oil and hydraulic fluid fumes contaminating aircraft cabin air conditioning systems have been well documented since the 1950s. Whilst organophosphates have been the main subject of interest, oil and hydraulic fumes in the air supply also contain ultrafine particles, numerous volatile organic hydrocarbons and thermally degraded products. We review the literature on the effects of fume events on aircrew health. Inhalation of these potentially toxic fumes is increasingly recognised to cause acute and long-term neurological, respiratory, cardiological and other symptoms. Cumulative exposure to regular small doses of toxic fumes is potentially damaging to health and may be exacerbated by a single higher-level exposure. Assessment is complex because of the limitations of considering the toxicity of individual substances in complex heated mixtures.There is a need for a systematic and consistent approach to diagnosis and treatment of persons who have been exposed to toxic fumes in aircraft cabins. The medical protocol presented in this paper has been written by internationally recognised experts and presents a consensus approach to the recognition, investigation and management of persons suffering from the toxic effects of inhaling thermally degraded engine oil and other fluids contaminating the air conditioning systems in aircraft, and includes actions and investigations for in-flight, immediately post-flight and late subsequent follow up.

Identifiants

pubmed: 37194087
doi: 10.1186/s12940-023-00987-8
pii: 10.1186/s12940-023-00987-8
pmc: PMC10186727
doi:

Substances chimiques

Organophosphates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43

Subventions

Organisme : NIEHS NIH HHS
ID : P42 ES004696
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

J Air Waste Manag Assoc. 2006 Jun;56(6):709-42
pubmed: 16805397
J Neurol Neurosurg Psychiatry. 2004 Sep;75 Suppl 3:iii29-34
pubmed: 15316042
Arch Environ Health. 2001 Mar-Apr;56(2):181-6
pubmed: 11339683
Environ Health Perspect. 2003 Apr;111(4):455-60
pubmed: 12676598
Klin Wochenschr. 1958 Jul 15;36(14):663-74
pubmed: 13576740
Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94
pubmed: 12406645
J Aviat Med. 1956 Feb;27(1):53-8
pubmed: 13286221
Eur Respir J. 2017 Feb 8;49(2):
pubmed: 28179436
Chirality. 2011 Nov;23(10):891-6
pubmed: 21953762
Nat Genet. 1993 Jan;3(1):73-6
pubmed: 8098250
Occup Environ Med. 2011 Mar;68(3):211-7
pubmed: 20921272
J Hazard Mater. 2011 Jun 15;190(1-3):150-8
pubmed: 21458918
Toxicol Appl Pharmacol. 1985 Mar 15;77(3):395-404
pubmed: 3919466
Chest. 2019 Feb;155(2):409-416
pubmed: 30419235
Indoor Air. 2016 Jun;26(3):478-88
pubmed: 25864418
Pharmacogenetics. 2000 Dec;10(9):767-79
pubmed: 11191881
Proc Am Thorac Soc. 2010 May;7(2):138-41
pubmed: 20427587
Part Fibre Toxicol. 2019 Jun 11;16(1):23
pubmed: 31182125
Pharmacol Ther. 2012 Jun;134(3):355-65
pubmed: 22465060
Environ Sci Technol. 2014 Jun 17;48(12):6995-7001
pubmed: 24844797
Arch Toxicol. 2017 Aug;91(8):2939-2952
pubmed: 28070599
Aquat Toxicol. 2012 Jun 15;114-115:173-81
pubmed: 22446829
J Immunol Res. 2019 Aug 6;2019:7406810
pubmed: 31687413
Environ Int. 2021 Nov;156:106718
pubmed: 34166876
Toxicol Sci. 2018 Mar 1;162(1):24-35
pubmed: 29228398
Lancet. 2000 Sep 2;356(9232):795-801
pubmed: 11022926
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
J Occup Environ Med. 1998 Nov;40(11):980-5
pubmed: 9830605
Brain Sci. 2020 Sep 05;10(9):
pubmed: 32899468
Environ Health. 2014 Mar 10;13(1):13
pubmed: 24612632
Neurotoxicol Teratol. 2017 May;61:36-46
pubmed: 28286177
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12780-4
pubmed: 18711144
Cancer Res. 2021 Aug 15;81(16):4360-4369
pubmed: 34167950
Environ Int. 2020 Aug;141:105779
pubmed: 32402984
Toxicology. 2018 Nov 1;409:44-52
pubmed: 30053494
Clin Toxicol (Phila). 2009 Mar;47(3):230-5
pubmed: 19267290
Annu Rev Pharmacol Toxicol. 1990;30:405-40
pubmed: 2188574
Cancers (Basel). 2021 Dec 31;14(1):
pubmed: 35008370
Toxicology. 2018 Dec 1;410:125-131
pubmed: 30266654
Chem Res Toxicol. 2011 Jun 20;24(6):797-808
pubmed: 21438623
Anal Biochem. 2014 Sep 15;461:17-26
pubmed: 24892986
Brain Res. 2010 Jul 23;1345:221-32
pubmed: 20546711
Mol Pharmacol. 2000 Sep;58(3):577-83
pubmed: 10953051
Lung. 2021 Apr;199(2):165-170
pubmed: 33719009
Toxicology. 2013 Dec 6;314(1):76-83
pubmed: 24051214
Brain Imaging Behav. 2016 Jun;10(2):437-44
pubmed: 26063438
J Toxicol Environ Health B Crit Rev. 2007 Dec;10(8):623-30
pubmed: 18049927
Toxicol Lett. 2016 May 13;249:22-8
pubmed: 27033775
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9193-9197
pubmed: 30150383
Indoor Air. 2021 Jul;31(4):926-957
pubmed: 33896039
Am J Ind Med. 2016 Jul;59(7):532-7
pubmed: 27184412
Lancet. 2002 Mar 2;359(9308):763-4
pubmed: 11888590
Ann Biol Clin (Paris). 2016 Jun 1;74(3):279-85
pubmed: 27237801
Chemosphere. 2015 Jan;119 Suppl:S58-61
pubmed: 24925093
Arch Toxicol. 1990;64(7):572-9
pubmed: 2073130
J Toxicol Environ Health A. 2016;79(22-23):1050-1056
pubmed: 27924713
J Toxicol Environ Health A. 1999 Jul 9;57(5):293-328
pubmed: 10405186
Environ Health. 2021 Aug 17;20(1):89
pubmed: 34404396
Toxicol Appl Pharmacol. 2011 Nov 1;256(3):337-47
pubmed: 21723309
J Biol Phys Chem. 2011;11:
pubmed: 24285929
BMJ. 2014 Jan 21;348:f7412
pubmed: 24452269
Br J Ind Med. 1960 Jul;17:190-200
pubmed: 13802477
Clin Toxicol (Phila). 2020 Feb;58(2):139-142
pubmed: 31092058
Neuro Oncol. 2014 Jul;16(7):896-913
pubmed: 24842956
BMJ Open. 2018 Sep 11;8(9):e022404
pubmed: 30206085
Neurotoxicol Teratol. 2010 Jul-Aug;32(4):452-9
pubmed: 20227490
Environ Res. 2002 Jun;89(2):146-64
pubmed: 12123648
Chem Res Toxicol. 2015 Apr 20;28(4):711-21
pubmed: 25706813
Neurotoxicology. 2014 Dec;45:209-15
pubmed: 25193069
Neurotox Res. 2018 Feb;33(2):316-336
pubmed: 28875469
Environ Int. 2020 Dec;145:106135
pubmed: 32979813
Biochem J. 1954 Feb;56(2):185-9
pubmed: 13140171
Environ Health. 2021 Aug 19;20(1):90
pubmed: 34412643
Toxicology. 2018 Aug 1;406-407:92-103
pubmed: 29894704
Clin Toxicol (Phila). 2020 May;58(5):414-416
pubmed: 31389264
Clin Toxicol. 1977;11(4):423-6
pubmed: 589955
J Toxicol Environ Health B Crit Rev. 1999 Oct-Dec;2(4):281-300
pubmed: 10596299
Biochem J. 2013 Sep 15;454(3):387-99
pubmed: 23782236
Chemosphere. 2016 Sep;158:116-23
pubmed: 27258902
Environ Int. 2016 Feb;87:74-84
pubmed: 26641522
Toxicology. 2018 Sep 1;408:101-112
pubmed: 30144465
Arch Environ Health. 2003 Aug;58(8):484-97
pubmed: 15259428
Endocr Rev. 2009 Jun;30(4):293-342
pubmed: 19502515
Allergol Select. 2018 Sep 1;2(1):80-88
pubmed: 31826033
BMC Public Health. 2018 Mar 23;18(1):346
pubmed: 29566648
Aviat Space Environ Med. 1983 Aug;54(8):738-40
pubmed: 6626083
Int J Epidemiol. 2016 Dec 1;45(6):1776-1786
pubmed: 26800751
Environ Pollut. 2020 Sep;264:114747
pubmed: 32559878
Arch Toxicol. 2013 Apr;87(4):645-8
pubmed: 23179756
Int J Epidemiol. 2016 Dec 1;45(6):1841-1851
pubmed: 28130316
J Toxicol Environ Health A. 2013;76(6):363-80
pubmed: 23557235
Toxicology. 2003 Mar 14;185(1-2):67-78
pubmed: 12505446
Drug Metab Dispos. 1995 Oct;23(10):1022-7
pubmed: 8654188
Circ Res. 2008 Mar 14;102(5):589-96
pubmed: 18202315
J Environ Sci (China). 2024 Jan;135:449-473
pubmed: 37778818
Nano Lett. 2009 Jan;9(1):36-43
pubmed: 19049393
Aviat Space Environ Med. 2001 Sep;72(9):821-6
pubmed: 11565817
Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96
pubmed: 26106142
Chem Biol Interact. 2013 Mar 25;203(1):257-64
pubmed: 23085349
Part Fibre Toxicol. 2005 Oct 21;2:10
pubmed: 16242040

Auteurs

Jonathan Burdon (J)

Respiratory Physician, St Vincent's Private Hospital, East Melbourne, Australia.

Lygia Therese Budnik (LT)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Xaver Baur (X)

European Society for Environmental and Occupational Medicine, Berlin, Germany.
University of Hamburg, Hamburg, Germany.

Gerard Hageman (G)

Department of Neurology, Medisch Spectrum Twente, Hospital Enschede, Enschede, The Netherlands.

C Vyvyan Howard (CV)

Centre for Molecular Biosciences, University of Ulster, Coleraine, Northern Ireland, UK.

Jordi Roig (J)

Department of Pulmonary Medicine, Clínica Creu Blanca, Barcelona, Spain.

Leonie Coxon (L)

Clinical and Forensic Psychologist, Mount Pleasant Psychology, Perth, Australia.

Clement E Furlong (CE)

Departments of Medicine (Div. Medical Genetics) and Genome Sciences, University of Washington, Seattle, USA.

David Gee (D)

Centre for Pollution Research and Policy, Visiting Fellow, Brunel University, London, UK.

Tristan Loraine (T)

Technical Consultant, Spokesperson for the Global Cabin Air Quality Executive, London, UK.

Alvin V Terry (AV)

Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, USA.

John Midavaine (J)

Lifemedic Bilthoven, Bilthoven, The Netherlands.

Hannes Petersen (H)

Faculty of Medicine, University of Iceland, Akureyri Hospital, Akureyri, Iceland.

Denis Bron (D)

Federal Department of Defence, Civil Protection and Sport (DDPS), Aeromedical Institute (FAI)/AeMC, Air Force, Dübendorf, Switzerland.

Colin L Soskolne (CL)

School of Public Health, University of Alberta, Edmonton, AB, Canada.

Susan Michaelis (S)

Occupational and Environmental Health Research Group, Honorary Senior Research Fellow, University of Stirling, Scotland / Michaelis Aviation Consulting, West Sussex, England. susan@susanmichaelis.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH